MiFoot
Study title
A Multifactorial Intervention to Improve Cardiovascular Outcomes in Adults with Type 2 Diabetes and Current or Previous Diabetes-related Foot Ulcers - randomised controlled trial (MiFoot RCT).
Funding and sponsorship
This project is funded by the National Institute of Health and Care Research (NIHR) under its Programme Grants for Applied Research, and Diabetes UK. It is sponsored by the University of Leicester.
Background
People with Type 2 diabetes and either a current or previous diabetes-related foot ulcer are often at high risk for future heart problems, such as heart attacks or strokes.
This may be caused by different factors such as difficulty in being physically active or managing their often complex condition. People might also find it more difficult to do every-day activities that are important to them, feel more anxious or depressed, and may need to use healthcare services more often.
Healthcare for people with diabetes-related foot ulcers is usually focussed on treating the ulcer, and not preventing long-term heart problems.
In this study we want to see whether the MiFoot programme can improve the health of people with current or previous diabetes-related foot ulcers, and if it is good value for money.
Study aims
Type 2 diabetes (T2D) is becoming more common and can lead to diabetes-related foot ulcer disease (DFUD). DFUD is a patch of broken skin on the foot that can be slow to heal and can come back easily. People with DFUD often also experience problems such as heart attacks and strokes. The MiFoot study is a research study that will test a programme designed to improve heart health in people with diabetes and diabetes-related foot ulcers. The MiFoot programme aims to help people to better manage their condition, receive the most up to date care and be more physically active.
The MiFoot programme includes:
Group-based education and exercise sessions
One to one session with a health care professional
Access to an online platform designed to support patients to live a healthy lifestyle
Study summary
Study progress
Actively recruiting
Study publications
Non-pharmacological interventions to improve cardiovascular risk factors in people with diabetic foot disease: A systematic review and meta-analysis https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(24)00074-3/fulltext
Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving sodiumglucose cotransporter-2 inhibitors versus other medications: A systematic review and meta-analysis of observational cohort studies https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15571
Data Protection
Chief Investigator – Professor Kamlesh Khunti.
If you would like any further information or have any questions, please contact the MiFoot study team on 0116 258 4732, Leicester Diabetes Centre, Monday to Friday 8:30am to 4:30pm or by email: mifoot@uhl-tr.nhs.uk.
Visit the study website: www.mifoot.org.uk